{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:07:45Z","timestamp":1792800465756,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007753","name":"University of Eastern Finland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007753","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Finnish Academy Centre of Excellence on Cardiovascular and Metabolic Diseases"},{"DOI":"10.13039\/100008723","name":"Finnish Medical Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Kuopio University Hospital","id":[{"id":"https:\/\/ror.org\/00fqdfs68","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["287478"],"award-info":[{"award-number":["287478"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005633","name":"Finnish Foundation for Cardiovascular Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004012","name":"Jane and Aatos Erkko Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>High grade serous ovarian carcinoma (HGSOC) is the most common subtype of epithelial ovarian cancers (EOC) with poor prognosis. In most cases EOC is widely disseminated at the time of diagnosis. Despite the optimal cytoreductive surgery and chemotherapy most patients develop chemoresistance, and the 5-year overall survival being only 25\u201335%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Here we analyzed the gene expression profiles of 10 primary HGSOC tumors and 10 related omental metastases using RNA sequencing and identified 100 differentially expressed genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The differentially expressed genes were associated with decreased embryogenesis and vasculogenesis and increased cellular proliferation and organismal death. Top upstream regulators responsible for this gene signature were NR5A1, GATA4, FOXL2, TP53 and BMP7. A subset of these genes were highly expressed in the ovarian cancer among the cancer transcriptomes of The Cancer Genome Atlas. Importantly, the metastatic gene signature was suggestive of poor survival in TCGA data based on gene enrichment analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>By comparing the gene expression profiles of primary HGSOC tumors and their matched metastasis, we provide evidence that a signature of 100 genes is able to separate these two sample types and potentially predict patient survival. Our study identifies functional categories of genes and transcription factors that could play important roles in promoting metastases and serve as markers for cancer prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-019-6339-0","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T01:03:03Z","timestamp":1574125383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Comparative\u00a0transcriptome analysis of matched primary and distant metastatic ovarian carcinoma"],"prefix":"10.1186","volume":"19","author":[{"given":"H.","family":"Sallinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Janhonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"P\u00f6l\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Niskanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. H.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kivel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hein\u00e4niemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yl\u00e4-Herttuala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. U.","family":"Kaikkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,19]]},"reference":[{"key":"6339_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","volume":"103","author":"J Ferlay","year":"2018","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356\u201387 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0959804918309559.","journal-title":"Eur J Cancer"},{"key":"6339_CR2","doi-asserted-by":"publisher","first-page":"E35","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E35\u2013E386. Available from:. https:\/\/doi.org\/10.1002\/ijc.29210.","journal-title":"Int J Cancer"},{"issue":"2","key":"6339_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.critrevonc.2013.08.017","volume":"89","author":"Pierre-Emmanuel Colombo","year":"2014","unstructured":"Colombo P, Fabbro M, Theillet C, Bibeau F, Rouanet P, Ray-Coquard I. Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer. Critical reviews in oncology\/hematology 2014;89:207. Available from. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24071502.","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"6339_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.humpath.2018.06.018","volume":"80","author":"J Prat","year":"2018","unstructured":"Prat J, D'Angelo E, Espinosa I. Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics. Hum Pathol. 2018;80:11\u201327 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0046817718302302.","journal-title":"Hum Pathol"},{"key":"6339_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jogc.2016.10.006","volume":"39","author":"G Bouchard-Fortier","year":"2016","unstructured":"Bouchard-Fortier G, Panzarella T, Rosen B, Chapman W, Gien L. Endometrioid carcinoma of the ovary: outcomes compared to serous carcinoma after 10 years of follow-up. J Obstet Gynaecol Can. 2016;39:34\u201341 Available from: https:\/\/www.clinicalkey.es\/playcontent\/1-s2.0-S1701216316397900.","journal-title":"J Obstet Gynaecol Can"},{"key":"6339_CR6","doi-asserted-by":"crossref","unstructured":"Lancaster J, Dressman H, Clarke J, Sayer R, Martino M, Cragun J, et al. Identification of genes associated with ovarian cancer metastasis using microarray expression analysis. Int J Gynecol Cancer 2006;16:1733\u20131745. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi? T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00009577\u2013200609000-00002.","DOI":"10.1111\/j.1525-1438.2006.00660.x"},{"key":"6339_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1479-5876-10-121","volume":"10","author":"JA Malek","year":"2012","unstructured":"Malek JA, Martinez A, Mery E, Ferron G, Huang R, Raynaud C, et al. Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis. J Transl Med. 2012;10:121 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22687175.","journal-title":"J Transl Med"},{"key":"6339_CR8","doi-asserted-by":"publisher","first-page":"e94476","DOI":"10.1371\/journal.pone.0094476","volume":"9","author":"AS Brodsky","year":"2014","unstructured":"Brodsky AS, Fischer A, Miller DH, Vang S, MacLaughlan S, Wu H, et al. Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease. PloS one. 2014;9:e94476 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24732363.","journal-title":"PloS one"},{"key":"6339_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ygyno.2018.10.002","volume":"152","author":"J Wang","year":"2019","unstructured":"Wang J, Dean DC, Hornicek FJ, Shi H, Duan Z. RNA sequencing (RNA-seq) and its application in ovarian cancer. Gynecol Oncol. 2019;152:194\u2013201 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0090825818312836.","journal-title":"Gynecol Oncol"},{"key":"6339_CR10","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","volume":"14","author":"RW Tothill","year":"2008","unstructured":"Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res. 2008;14:5198\u2013208 Available from: http:\/\/clincancerres.aacrjournals.org\/content\/14\/16\/5198.abstract.","journal-title":"Clin Cancer Res"},{"key":"6339_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"D Bell","year":"2011","unstructured":"Bell D, Berchuck A, Birrer M, Chien J, Dao F, Dhir R, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609\u201315 Available from: http:\/\/www.narcis.nl\/publication\/RecordID\/oai:pure.rug.nl:publications%2F33430660-3aa7-45f5-a1fc-ffdef7fd2894.","journal-title":"Nature"},{"issue":"20","key":"6339_CR12","doi-asserted-by":"publisher","first-page":"12570","DOI":"10.1093\/nar\/gku1036","volume":"42","author":"Minna U. Kaikkonen","year":"2014","unstructured":"Kaikkonen MU, Niskanen H, Romanoski CE, Kansanen E, Kivel\u00e4 AM, Laitalainen J, et al. Control of VEGF-A transcriptional programs by pausing and genomic compartmentalization. Nucleic acids research 2014;42:12570-84. Available from. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25352550.","journal-title":"Nucleic Acids Research"},{"issue":"4","key":"6339_CR13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"Kenneth J. Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method. Methods 2001;25:402-8. Available from. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"key":"6339_CR14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38:576\u201389 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1097276510003667.","journal-title":"Mol Cell"},{"issue":"9","key":"6339_CR15","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/nprot.2013.099","volume":"8","author":"Simon Anders","year":"2013","unstructured":"Anders S, Mccarthy DJ, Chen Y, Okoniewski M, Smyth GK, Huber W, et al. Count-based differential expression analysis of RNA sequencing data using R and bioconductor. Nature protocols 2013;8:1765. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23975260.","journal-title":"Nature Protocols"},{"issue":"9","key":"6339_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/bioinformatics\/bth078","volume":"20","author":"M.J.L. de Hoon","year":"2004","unstructured":"de Hoon M, Imoto S, Nolan J, Miyano S. Open source clustering software. Bioinformatics 2004;20:1453-4. Available from. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14871861.","journal-title":"Bioinformatics"},{"issue":"17","key":"6339_CR17","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1093\/bioinformatics\/bth349","volume":"20","author":"A. J. Saldanha","year":"2004","unstructured":"Saldanha AJ. Java treeview--extensible visualization of microarray data. Bioinformatics 2004;20:3246-8. Available from. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15180930.","journal-title":"Bioinformatics"},{"key":"6339_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"BT Sherman","year":"2008","unstructured":"Sherman BT, Lempicki RA, Huang DW. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2008;4:44\u201357. Available from:. https:\/\/doi.org\/10.1038\/nprot.2008.211.","journal-title":"Nat Protoc"},{"key":"6339_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23323831.","journal-title":"BMC Bioinformatics"},{"key":"6339_CR20","doi-asserted-by":"publisher","first-page":"e04207","DOI":"10.7554\/eLife.04207","volume":"3","author":"A Georges","year":"2014","unstructured":"Georges A, L'H\u00f4te D, Todeschini AL, Auguste A, Legois B, Zider A, et al. The transcription factor FOXL2 mobilizes estrogen signaling to maintain the identity of ovarian granulosa cells. eLife. 2014;3:e04207 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25369636.","journal-title":"eLife"},{"key":"6339_CR21","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1093\/hmg\/ddy312","volume":"27","author":"B Nicol","year":"2018","unstructured":"Nicol B, Grimm SA, Gruzdev A, Scott GJ, Ray MK, Yao HH. Genome-wide identification of FOXL2 binding and characterization of FOXL2 feminizing action in the fetal gonads. Human molecular genetics. 2018;27:4273\u201387 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30212841.","journal-title":"Human molecular genetics"},{"key":"6339_CR22","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010;177:1053\u201364 Available from: https:\/\/www.clinicalkey.es\/playcontent\/1-s2.0-S0002944010601605.","journal-title":"Am J Pathol"},{"key":"6339_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ng1060","volume":"33","author":"KN Ross","year":"2003","unstructured":"Ross KN, Ramaswamy S, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet. 2003;33:49\u201354. Available from:. https:\/\/doi.org\/10.1038\/ng1060.","journal-title":"Nat Genet"},{"key":"6339_CR24","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/erm.2016.2","volume":"18","author":"MH Lentjes","year":"2016","unstructured":"Lentjes MH, Niessen HE, Akiyama Y, de Bru\u00efne AP, Melotte V, van Engeland M. The emerging role of GATA transcription factors in development and disease. Expert Rev Mol Med. 2016;18:e3 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26953528.","journal-title":"Expert Rev Mol Med"},{"issue":"7","key":"6339_CR25","doi-asserted-by":"publisher","first-page":"e6454","DOI":"10.1371\/journal.pone.0006454","volume":"4","author":"Kathy Qi Cai","year":"2009","unstructured":"Cai KQ, Caslini C, Capo-chichi CD, Slater S, Smith ER, Wu H, et al. Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia, PLoS one. 2009;4:e6454 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19649254.","journal-title":"PLoS ONE"},{"key":"6339_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.canlet.2005.10.039","volume":"241","author":"K Wakana","year":"2006","unstructured":"Wakana K, Akiyama Y, Aso T, Yuasa Y. Involvement of GATA-4\/\u22125 transcription factors in ovarian carcinogenesis. Cancer Lett. 2006;241:281\u20138 Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0304383505009584.","journal-title":"Cancer Lett"},{"issue":"4","key":"6339_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.5507\/bp.2013.079","volume":"157","author":"Marcela Chmelarova","year":"2013","unstructured":"Chmelarova M, Dvorakova E, Spacek J, Laco J, Palicka V. Importance of promoter methylation of GATA4 gene in epithelial ovarian cancer. Biomedical papers of the medical Faculty of the University Palack\u00fd, Olomouc, Czechoslovakia 2013;157:294. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24145767.","journal-title":"Biomedical Papers"},{"key":"6339_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/PAI.0b013e31815b629c","volume":"16","author":"MD McEachin","year":"2008","unstructured":"McEachin MD, Xu X, Santoiainni RA, Lawson D, Cotsonis G, Cohen C. GATA-4 and GATA-6 expression in human ovarian surface epithelial carcinoma. Appl Immunohistochem Mol Morphol. 2008;16:153\u20138 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18227727.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"6339_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/cge.12932\/abstract","volume":"91","author":"A Bashamboo","year":"2017","unstructured":"Bashamboo A, Eozenou C, Rojo S, McElreavey K. Anomalies in human sex determination provide unique insights into the complex genetic interactions of early gonad development. Clin Genet. 2017;91:143\u201356. Available from:. https:\/\/doi.org\/10.1111\/cge.12932\/abstract.","journal-title":"Clin Genet"},{"issue":"3","key":"6339_CR30","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s13277-014-2187-3","volume":"36","author":"Zhuo-ying Hu","year":"2015","unstructured":"Hu Z-y, Tang L-d, Zhang H-y, Niu J-y, Lou M. Clinicopathological significance of steroidogenic factor-1 expression in ovarian cancer versus ovarian sex cord stromal tumor. Tumor Biol 2015;36:1429-1435. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25604140.","journal-title":"Tumor Biology"},{"key":"6339_CR31","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa0806228","volume":"360","author":"D Lourenco","year":"2009","unstructured":"Lourenco D, Brauner R, Lin L, De Perdigo A, Weryha G, Muresan M, et al. Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med. 2009;360:1200\u201310 Available from: http:\/\/content.nejm.org\/cgi\/content\/abstract\/360\/12\/1200.","journal-title":"N Engl J Med"},{"key":"6339_CR32","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1126\/science.aan2507","volume":"357","author":"M Uhlen","year":"2017","unstructured":"Uhlen M, Zhang C, Lee S, Sjostedt E, Fagerberg L, Bidkhori G, et al. A pathology atlas of the human cancer transcriptome. Science. 2017;357:660 Available from: https:\/\/research.chalmers.se\/publication\/251875.","journal-title":"Science"},{"key":"6339_CR33","first-page":"R1","volume":"52","author":"A Georges","year":"2014","unstructured":"Georges A, Auguste A, Bessi\u00e8re L, Vanet A, Todeschini A, Veitia RA. FOXL2: a central transcription factor of the ovary. J Mol Endocrinol. 2014;52:R1\u2013R33 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24049064.","journal-title":"J Mol Endocrinol"},{"key":"6339_CR34","doi-asserted-by":"publisher","first-page":"14207","DOI":"10.18632\/oncotarget.7422","volume":"7","author":"M Alexiadis","year":"2016","unstructured":"Alexiadis M, Chu S, Leung D, Gould JA, Jobling T, Fuller PJ. Transcriptomic analysis of stage 1 versus advanced adult granulosa cell tumors. Oncotarget. 2016;7:14207 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26893359.","journal-title":"Oncotarget"},{"issue":"10","key":"6339_CR35","doi-asserted-by":"publisher","first-page":"e0205494","DOI":"10.1371\/journal.pone.0205494","volume":"13","author":"Masayoshi Fujisawa","year":"2018","unstructured":"Fujisawa M, Moh-Moh-Aung A, Zeng Z, Yoshimura T, Wani Y, Matsukawa A. Ovarian stromal cells as a source of cancer-associated fibroblasts in human epithelial ovarian cancer: a histopathological study. PLoS one, Available from. 2018;13:e0205494 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30304016.","journal-title":"PLOS ONE"},{"key":"6339_CR36","doi-asserted-by":"publisher","first-page":"e0206785","DOI":"10.1371\/journal.pone.0206785","volume":"13","author":"AJ Shih","year":"2018","unstructured":"Shih AJ, Menzin A, Whyte J, Lovecchio J, Liew A, Khalili H, et al. Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq. PLoS one. 2018;13:e0206785 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30383866.","journal-title":"PLoS one"},{"key":"6339_CR37","doi-asserted-by":"publisher","first-page":"dju249","DOI":"10.1093\/jnci\/dju249","volume":"106","author":"GE Konecny","year":"2014","unstructured":"Konecny GE, Wang C, Hamidi H, Winterhoff B, Kalli KR, Dering J, et al. Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer. J Natl Cancer Inst. 2014;106:dju249 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25269487.","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"6339_CR38","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1158\/1078-0432.CCR-17-0246","volume":"23","author":"Chen Wang","year":"2017","unstructured":"Wang C, Armasu SM, Kalli KR, Maurer MJ, Heinzen EP, Keeney GL, et al. Pooled clustering of high-grade serous ovarian cancer gene expression leads to novel consensus subtypes associated with survival and surgical outcomes. Clinical Cancer research : an official journal of the American Association for Cancer Research 2017;23:4077-4085. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28280090.","journal-title":"Clinical Cancer Research"},{"key":"6339_CR39","doi-asserted-by":"crossref","unstructured":"Wang X, Wang S-s, Zhou L, Yu L, Zhang L-m. A network-pathway based module identification for predicting the prognosis of ovarian cancer patients. J Ovarian Res 2016;9. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5093979\/.","DOI":"10.1186\/s13048-016-0285-0"},{"key":"6339_CR40","doi-asserted-by":"publisher","first-page":"8404","DOI":"10.1158\/0008-5472.CAN-06-0683","volume":"66","author":"JS Sunde","year":"2006","unstructured":"Sunde JS, Donninger H, Wu K, Johnson ME, Pestell RG, Rose GS, et al. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-{beta} signaling in ovarian cancer. Cancer Res. 2006;66:8404\u201312 Available from: http:\/\/cancerres.aacrjournals.org\/cgi\/content\/abstract\/66\/17\/8404.","journal-title":"Cancer Res"},{"key":"6339_CR41","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3892\/mmr.2015.3489","volume":"12","author":"T Liu","year":"2015","unstructured":"Liu T, Yu N, Ding F, Wang S, Li S, Zhang X, et al. Verifying the markers of ovarian cancer using RNA-seq data. Mol Med Rep. 2015;12:1125\u201330 Available from: https:\/\/www.spandidos-publications.com\/mmr\/12\/1\/1125.","journal-title":"Mol Med Rep"},{"key":"6339_CR42","first-page":"2659","volume":"40","author":"X Wang","year":"2018","unstructured":"Wang X, Han L, Zhou L, Wang L, Zhang L. Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network. Oncol reports. 2018;40:2659\u201373 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30226545.","journal-title":"Oncol reports"},{"key":"6339_CR43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery. 2012;2:401\u20134 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22588877.","journal-title":"Cancer Discovery"},{"key":"6339_CR44","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23550210.","journal-title":"Sci Signal"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6339-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6339-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6339-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T22:59:20Z","timestamp":1605653960000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6339-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6339"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6339-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,19]]},"assertion":[{"value":"14 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the joint Ethical Committee of Kuopio University Hospital and University of Eastern Finland and written informed consent was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1121"}}